BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 2839658)

  • 61. Effects of different opiates on hypothalamic monoamine turnover and on plasma LH levels in pro-oestrous rats.
    Gopalan C; Gilmore DP; Brown CH
    J Neurol Sci; 1989 Dec; 94(1-3):211-9. PubMed ID: 2559164
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Luteinizing hormone sensitivity to naloxone in maturing male chimpanzees.
    Blank MS; Murphy JR
    Brain Res Bull; 1991 Aug; 27(2):241-5. PubMed ID: 1742612
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effects of opiate agonists and antagonists on cerebral metabolic activity in the conscious rat.
    Stein EA; Fuller SA
    NIDA Res Monogr; 1990; 105():395-6. PubMed ID: 1876051
    [No Abstract]   [Full Text] [Related]  

  • 64. A possible role of the pineal gland in acute immobilization-related suppression of naloxone-induced LH release in ovariectomized estrogen-primed rats.
    Chiba A; Akema T; Iigo M; Nagami Y; Kimura F; Toyoda J
    J Neuroendocrinol; 1998 Feb; 10(2):79-84. PubMed ID: 9535053
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Delta opioid receptors are involved in morphine-induced inhibition of luteinizing hormone releasing hormone in SK-N-SH cells.
    Bennett L; Ratka A
    Neuropeptides; 2003 Oct; 37(5):264-70. PubMed ID: 14607103
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Alterations in the opioid control of LHRH release from hypothalami isolated from aged male rats.
    Nazian SJ; Landon CS; Dietz JR
    J Gerontol A Biol Sci Med Sci; 1998 May; 53(3):B191-5. PubMed ID: 9597043
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Kappa-opioid receptor involvement in the regulation of pulsatile luteinizing hormone release during early pregnancy in the rat.
    Gallo RV
    J Neuroendocrinol; 1990 Oct; 2(5):685-91. PubMed ID: 19215406
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Treatment of lactating sows with the dopamine agonist Cabergoline: effects on LH and prolactin secretion and responses to challenges with naloxone and morphine.
    De Rensis F; Quintavalla F; Foxcroft GR
    Anim Reprod Sci; 1998 May; 51(3):233-47. PubMed ID: 9675405
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Monoaminergic antagonists which block naloxone-induced release of luteinizing hormone bind selectively to hypothalamic opiate receptors.
    Blank MS; Diez JA; Roberts DL
    Brain Res; 1983 Nov; 279(1-2):153-8. PubMed ID: 6315167
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Different types of opioid receptors involved in the suppression of LH secretion in lactating sheep.
    Dobek E; Górski K; Romanowicz K; Misztal T
    Anim Reprod Sci; 2013 Sep; 141(1-2):62-7. PubMed ID: 23953813
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Morphine has a dual concentration-dependent effect on K(+)-evoked substance P release from rat peripheral airways.
    Cabot PJ; Cramond T; Smith MT
    Pulm Pharmacol Ther; 1997 Aug; 10(4):215-21. PubMed ID: 9695145
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Development and control of the opioid inhibition of gonadotropin secretion during the sexual maturation of the male rat.
    Nazian SJ
    Neuroendocrinology; 1992 Jun; 55(6):613-20. PubMed ID: 1630582
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effects of mu, kappa, and delta opioid receptor agonists and antagonists on rat hypothalamic noradrenergic neurotransmission.
    Yilmaz B; Gilmore DP
    Brain Res Bull; 1999 Mar; 48(5):491-5. PubMed ID: 10372509
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effect of prior nicotine treatment on drug induced changes in serum LH concentrations in rats.
    Hodson CA; Davis MC; Burden HW
    Life Sci; 1997; 60(25):2303-8. PubMed ID: 9194685
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Stress-induced suppression of luteinizing hormone concentrations in wild baboons: role of opiates.
    Sapolsky RM; Krey LC
    J Clin Endocrinol Metab; 1988 Apr; 66(4):722-6. PubMed ID: 2831246
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Dual label in situ hybridization studies provide evidence that luteinizing hormone-releasing hormone neurons do not synthesize messenger ribonucleic acid for mu, kappa, or delta opiate receptors.
    Sannella MI; Petersen SL
    Endocrinology; 1997 Apr; 138(4):1667-72. PubMed ID: 9075729
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effects of opiate antagonists on serotonin turnover and on luteinizing hormone and prolactin secretion in estrogen- or morphine-treated rats.
    Johnson MD; Crowley WR
    Neuroendocrinology; 1984 Apr; 38(4):322-7. PubMed ID: 6328344
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Diurnal influences on serum luteinizing hormone responses to opiate receptor blockade with naloxone or to luteinizing hormone-releasing hormone in the immature female rat.
    Blank MS; Mann DR
    Proc Soc Exp Biol Med; 1981 Dec; 168(3):338-43. PubMed ID: 6275395
    [No Abstract]   [Full Text] [Related]  

  • 79. An in vivo assay for the analysis of the biological potency and structure-activity relationships of narcotics: serum testosterone depletion in the male rat.
    Cicero TJ
    J Pharmacol Exp Ther; 1977 Sep; 202(3):670-5. PubMed ID: 19620
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effects of a sustained-release naloxone pellet on luteinizing hormone secretion in female rats.
    Gabriel SM; Simpkins JW
    Neuroendocrinology; 1983 Nov; 37(5):342-8. PubMed ID: 6139759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.